Search MedicineSir
Disclaimer: Content on MedicineSir is for educational and informational purposes only and does not substitute for professional medical advice. Read More

Telmisartan, Metoprolol and Cilnidipine Tablet - Uses, Side effects, Warnings, Interaction

Telmisartan Metoprolol and Cilnidipine Tablet

Telmisartan + Metoprolol + Cilnidipine Tablet: Quick Summary

Uses, benefits, side effects, dosage & important warnings

๐Ÿ’Š
Medicine Name Telmisartan + Metoprolol + Cilnidipine Tablet
๐Ÿงฌ
Active Ingredients Telmisartan + Metoprolol + Cilnidipine
๐Ÿ”ฌ
Drug Class Angiotensin II Receptor Blocker (ARB) + Beta-Blocker + Calcium Channel Blocker
❤️
Uses Treatment of high blood pressure and, when specifically prescribed, certain cardiovascular conditions
๐Ÿ“‰
Benefits Helps lower blood pressure through complementary mechanisms while metoprolol also reduces heart rate and cardiac workload
⚠️
Side Effects Dizziness, fatigue, low blood pressure, slow heart rate, headache, ankle swelling and flushing may occur
๐Ÿ’‰
Common Strengths Combination strengths vary by manufacturer and product; use only the prescribed strength
๐Ÿ“‹
Dosage Dose is individualized according to blood pressure, heart rate, kidney function and response to treatment
๐Ÿฝ️
How to Take Take exactly as prescribed, preferably at the same time each day
⚙️
How It Works Telmisartan blocks angiotensin II, cilnidipine relaxes blood vessels and metoprolol slows the heart rate
๐Ÿฉบ
Monitoring Blood pressure, heart rate, kidney function and potassium may require monitoring
๐Ÿšซ
Important Do not suddenly stop metoprolol or change the dose without medical advice
๐Ÿ“‰ Low Blood Pressure Warning:
The combination can lower blood pressure significantly in some patients. Dizziness, weakness or fainting may occur, particularly when treatment is started or doses are increased.
❤️ Slow Heart Rate Warning:
Metoprolol can slow the heart rate. Contact your healthcare professional if you develop severe dizziness, fainting, unusual weakness or an unusually slow heartbeat.
๐Ÿฉบ Kidney Function Warning:
Telmisartan may affect kidney function in susceptible patients. Kidney function and potassium may need monitoring, particularly in people with kidney disease or dehydration.
๐Ÿงช Potassium Warning:
Telmisartan may increase potassium levels. Avoid potassium supplements or potassium-containing salt substitutes unless specifically recommended by your healthcare professional.
๐Ÿฆถ Ankle Swelling Warning:
Cilnidipine may cause swelling of the ankles or feet in some patients. Inform your doctor if swelling is persistent, severe or worsening.
⚠️ NSAID Interaction:
NSAIDs such as ibuprofen, diclofenac and naproxen may reduce the blood-pressure-lowering effect of telmisartan and may increase the risk of kidney problems in susceptible patients.
๐Ÿšซ Do Not Stop Suddenly:
Metoprolol should generally not be stopped abruptly because sudden withdrawal can worsen angina or other heart problems. Any dose reduction should be done under medical supervision.
๐Ÿคฐ Pregnancy Warning:
Telmisartan should not be used during pregnancy because medicines that block the renin-angiotensin system can cause serious fetal harm. Contact your doctor immediately if pregnancy occurs.